Latest Feature

Sequent Medical CEO Wilder bets on braids

Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pus

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Hansen Medical launches 3rd-gen Sensei surgical robot

October 31, 2014 by Val Kennedy

Hansen Medical says its 3rd-generation Sensei X2 robot-assisted surgery device won an FDA nod for use in heart procedures.

Hansen Medical launches 3rd-gen Sensei surgical robot for stent procedures

U.S. sales narrow HeartWare's Q3 losses

October 31, 2014 by Val Kennedy

HeartWare posts narrowed 3rd-quarter losses thanks to increased sales of its implantable heart pumps in the U.S.

U.S. sales narrow HeartWare's Q3 losses

HeartWare International (NSDQ:HTWR) yesterday reported narrowed 3rd-quarter losses and significantly higher revenues, boosted by a 39% jump in U.S. sales of its implantable heart pumps.

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Medtronic CEO Omar Ishrak unveils the plan for the medical device giant's management structure after it closes its mega-merger with Covidien early next year.

Medtronic unveils post-merger management structure

MassDevice.com +3 | The top 3 medtech stories for October 30, 2014

October 30, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Pelvic mesh lawsuits push Coloplast's annual profits down

October 30, 2014 by Brad Perriello

Coloplast posts its 1st profits decline in 7 years on mounting legal costs stemming from U.S. product liability lawsuits filed over its pelvic mesh products.

Pelvic mesh lawsuits push Coloplast's annual profits down

Smith & Nephew gains on Q3 results

October 30, 2014 by Brad Perriello

Shares of Smith & Nephew are up today on solid 3rd-quarter results, including 6% growth for its U.S. hip implant business.

Smith & Nephew gains on Q3 results

Abiomed jumps on FDA deal for Impella indication

October 30, 2014 by Brad Perriello

Abiomed says it's come to an agreement with the FDA on an indication for its flagship Impella 2.5 heart pump, and now expects to win pre-market approval early next year without a hearing before an FDA advisory panel.

Abiomed jumps on deal with FDA
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp